[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Joint & Vascular Institute\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":121},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,48,71,98],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100643064","prospective-hemorrhoidal-embolisation-piles-registry-100643064",false,"NCT07635784","Prospective HemorrhoIdaL EmboliSation (PILES) Registry","Creation Of a Prospective Registry For Hemorrhoid Artery Embolization At The Joint & Vascular Institute","PILES","Inclusion Criteria:\n\n* Adults (≥18 years) with symptomatic bleeding internal hemorrhoids refractory to medical therapy, referred for HAE.\n\nExclusion Criteria:\n\n* Pregnancy, coagulopathy, severe comorbidities, or inability to consent.","ALL","18 Years",{"count":20,"type":21},1200,"ESTIMATED","5 Years","OBSERVATIONAL","The goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of hemorrhoid artery embolization (HAE) for symptomatic bleeding internal hemorrhoids in adults aged 18 years or older that have not responded to medical therapy.\n\nThe main question it aims to answer are:\n\n1\\) Does HAE lead to sustained improvement in bleeding (HDSS scores over 12-36 months?\n\nParticipants will:\n\n* Undergo HAE as part of their routine clinical care.\n* Complete clinical follow-up assessments at 1, 3, 6, 12, 18, 24, and 36 months after treatment, including symptom and quality-of-life questionnaires.\n* Have safety outcomes tracked according to Society of Interventional Radiology guidelines.\n\nThere is no comparison group; results will be analyzed to identify predictors of success and inform best practices for patient selection and treatment.",[26,27,28,29,30],"Hemorrhoid","Internal Hemorrhoids","Hemorrhoid Bleeding","Hemorrhoidal Bleeding","Internal Hemorrhoid",[32,33,34],"bleeding","hemorrhoids","internal hemorrhoids","RECRUITING","2026-06-10",{"date":38,"type":39},"2026-06-12","ACTUAL",{"date":41,"type":39},"2026-01-18",{"date":43,"type":21},"2032-01",{"name":45,"class":46},"Joint & Vascular Institute","INDUSTRY",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":56,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":65,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":47},"100622229","genicular-artery-embolization-for-knee-osteoarthritis-rambo-registry-100622229","NCT07380906","geniculaR Artery eMBolization for Knee Osteoarthritis (RAMBO) Registry","Creation Of a Prospective Registry For Genicular Artery Embolization At The Joint & Vascular Institute","RAMBO","Inclusion Criteria:\n\n* Adults (≥18 years) with symptomatic KOA refractory to medical therapy, referred for GAE.\n\nExclusion Criteria:\n\n* Pregnancy, coagulopathy, severe comorbidities, or inability to consent.",{"count":20,"type":21},"The goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of genicular artery embolization (GAE) for knee osteoarthritis in adults aged 18 years or older with symptomatic KOA that has not responded to medical therapy.\n\nThe main questions it aims to answer are:\n\n1. Does GAE lead to sustained improvement in pain (WOMAC, VAS) and quality-of-life scores over 12-36 months?\n2. What patient or procedural factors are associated with better outcomes after GAE?\n\nParticipants will:\n\n* Undergo GAE as part of their routine clinical care.\n* Complete clinical follow-up assessments at 1, 3, 6, 12, 18, 24, and 36 months after treatment, including symptom and quality-of-life questionnaires.\n* Have safety outcomes tracked according to Society of Interventional Radiology guidelines.\n\nThere is no comparison group; results will be analyzed to identify predictors of success and inform best practices for patient selection and treatment.",[59],"Knee Osteoarthristis",[61,62,63,64],"knee osteoarthritis","embolization","GAE","Genicular Artery Embolization",{"date":38,"type":39},{"date":67,"type":39},"2025-07-16",{"date":69,"type":21},"2030-07",{"name":45,"class":46},{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":4,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":17,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":4,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":47},"100629683","phase-1-achilles-tendinopathy-embolization-100629683","NCT07477860","Achilles Tendinopathy Embolization","Achilles Tendinopathy Embolization (ATE) With LipioJoint: An Early Feasibility Study","Inclusion Criteria:\n\n* Age ≥ 25 years\n* Subject provides written informed consent\n* Patient with Achilles tendinopathy refractory to 3 months of conservative management\n* Self reported pain of at least 4\u002F10 on visual analog scale (VAS)\n* Non-surgical candidate\u002Flooking to avoid surgery\n\nExclusion Criteria:\n\n* Achilles tendon pain caused by acute fracture, recent trauma, inflammatory conditions, muscle\u002Fligament injury, tendon rupture, and etiologies related to bone mineral density\n* Steroid injection in the last 90 days from the embolization procedure\n* Known severe allergy to Lipiodol and\u002For iodinated contrast media\n* Diagnosis of peripheral arterial disease affecting the lower extremities\n* Pregnancy or breastfeeding\n* Anticoagulation or irreversible coagulopathy\n* GFR \\\u003C45 or Serum creatinine \\> 2.0 mg\u002Fdl\n* Type 1 Diabetes Mellitus","25 Years","80 Years",{"count":81,"type":21},10,"INTERVENTIONAL",[84],"PHASE1","The goal of this clinical trial is to learn determine the feasibility of arterial embolization using Lipiodol emulsion to safely and effectively treat chronic Achilles tendon pain due to Achilles tendinopathy in adults aged 25 to 80. The main questions it aims to answer are:\n\n1. Does this procedure successfully reduce chronic Achilles tendon pain as measured by the Visual Analog Scale (VAS) over 12 months?\n2. How safe is the procedure, specifically regarding the frequency of serious medical problems or adverse events related to the device?\n\nParticipants will:\n\n* Undergo a minimally invasive procedure where a doctor uses a small tube (catheter) to inject a temporary blocking agent (LipioJoint) into specific blood vessels supplying the Achilles tendon.\n* Receive a phone call one day after the procedure to check for early side effects.\n* Participate in four follow-up visits over the course of one year (at 1, 3, 6, and 12 months).\n\nComplete pain intensity surveys (VAS) and report any changes in their use of other therapies or medications during these visits.",[87],"Achilles Tendinopathy (AT)",[89],"achilles","2026-04-20",{"date":92,"type":39},"2026-04-23",{"date":94,"type":39},"2026-04-01",{"date":96,"type":21},"2028-03",{"name":45,"class":46},{"id":99,"slug":100,"hasResults":11,"nctId":101,"briefTitle":102,"officialTitle":103,"acronym":4,"eligibilityCriteria":104,"healthyVolunteers":11,"sex":17,"minAge":78,"maxAge":79,"enrollmentInfo":105,"targetDuration":4,"studyType":82,"phases":106,"briefSummary":107,"conditions":108,"keywords":111,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":47},"100623322","phase-1-lateral-plantar-artery-embolization-for-plantar-fasciitis-100623322","NCT07395128","Lateral Plantar Artery Embolization For Plantar Fasciitis","Lateral Plantar Artery Embolization to Treat Pain Chronic Heel Pain Due To Plantar Fasciitis A Pilot Study to Assess Feasibility","Inclusion Criteria:\n\n* Age ≥ 25 years\n* Subject provides written informed consent\n* Patient with Plantar Fasciitis refractory to 3 months of conservative management\n* Self reported pain of at least 4\u002F10 on visual analog scale (VAS)\n* Non-surgical candidate\u002Flooking to avoid surgery\n\nExclusion Criteria:\n\n* Heel pain caused by acute fracture, recent trauma, inflammatory conditions, muscle\u002Fligament injury, and etiologies related to bone mineral density.\n* Steroid injection in the last 90 days from the embolization procedure\n* Known severe allergy to Lipiodol and\u002For iodinated contrast media\n* Diagnosis of peripheral arterial disease affecting the lower extremities\n* Pregnancy or breastfeeding\n* Anticoagulation or irreversible coagulopathy\n* GFR \\\u003C45 or Serum creatinine \\> 2.0 mg\u002Fdl\n* Type 1 Diabetes Mellitus",{"count":81,"type":21},[84],"The goal of this clinical trial is to learn if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain due to plantar fasciitis in adults aged 25 to 80. The main questions it aims to answer are:\n\nDoes this procedure successfully reduce chronic heel pain as measured by the Visual Analog Scale (VAS) over 12 months?\n\nHow safe is the procedure, specifically regarding the frequency of serious medical problems or adverse events related to the device?\n\nParticipants will:\n\nUndergo a minimally invasive procedure where a doctor uses a small tube (catheter) to inject a temporary blocking agent (LipioJoint) into specific blood vessels in the foot.\n\nReceive a phone call one day after the procedure to check for early side effects.\n\nParticipate in four follow-up telehealth visits over the course of one year (at 1, 3, 6, and 12 months).\n\nComplete pain intensity surveys (VAS) and report any changes in their use of other therapies or medications during these visits.",[109,110],"Plantar Fasciitis, Chronic","Plantar Fasciitis",[112],"plantar fasciitis","2026-02-05",{"date":115,"type":39},"2026-02-09",{"date":117,"type":39},"2025-12-20",{"date":119,"type":21},"2027-03",{"name":45,"class":46},""]